Zobrazeno 1 - 10
of 100
pro vyhledávání: '"Doris Hillemann"'
Autor:
Irina Kontsevaya, Jan Heyckendorf, Frauke Koops, Doris Hillemann, Torsten Goldmann, Caryn M. Upton, Veronique De Jager, Andreas Diacon, Christoph Lange
Publikováno v:
Microbiology Spectrum, Vol 11, Iss 6 (2023)
ABSTRACT We assessed the performance of a novel real-time PCR-based transrenal DNA (trDNA) assay for the specific detection of Mycobacterium tuberculosis as a candidate marker of the early anti-tuberculosis therapy response. The study was performed o
Externí odkaz:
https://doaj.org/article/adb1a09c98f64eab8c5246dae185bfa0
Autor:
Rachel F. Rollo, Giorgia Mori, Timothy A. Hill, Doris Hillemann, Stefan Niemann, Susanne Homolka, David P. Fairlie, Antje Blumenthal
Publikováno v:
Microbiology Spectrum, Vol 11, Iss 4 (2023)
ABSTRACT Shorter and more effective treatment regimens as well as new drugs are urgent priorities for reducing the immense global burden of tuberculosis (TB). As treatment of TB currently requires multiple antibiotics with diverse mechanisms of actio
Externí odkaz:
https://doaj.org/article/833f0bedf8da40d99d8b123434117953
Autor:
Niklas Köhler, Hande Karaköse, Hans-Peter Grobbel, Doris Hillemann, Sönke Andres, Christina König, Barbara Kalsdorf, Thomas Theo Brehm, Laura Böttcher, Inna Friesen, Harald Hoffmann, Dražen Strelec, Dagmar Schaub, Charles A. Peloquin, Stefan Schmiedel, Laurent A. Decosterd, Eva Choong, Sebastian G. Wicha, Rob E. Aarnoutse, Christoph Lange, Patricia M. Sánchez Carballo
Publikováno v:
Pharmaceutics, Vol 15, Iss 11, p 2543 (2023)
The treatment of drug-resistant Mycobacterium tuberculosis relies on complex antibiotic therapy. Inadequate antibiotic exposure can lead to treatment failure, acquired drug resistance, and an increased risk of adverse events. Therapeutic drug monitor
Externí odkaz:
https://doaj.org/article/61ae5ab8f27c42b5814e8e04b54b71a2
Autor:
Susanne Homolka, Laura Paulowski, Sönke Andres, Doris Hillemann, Ruwen Jou, Gunar Günther, Mareli Claassens, Martin Kuhns, Stefan Niemann, Florian P. Maurer
Publikováno v:
Emerging Infectious Diseases, Vol 26, Iss 11, Pp 2549-2554 (2020)
In many settings, the ongoing coronavirus disease (COVID-19) pandemic coincides with other major public health threats, in particular tuberculosis. Using tuberculosis (TB) molecular diagnostic infrastructure, which has substantially expanded worldwid
Externí odkaz:
https://doaj.org/article/762934f1ee3040c7bee534d21787d5c0
Autor:
Yassir A. Shuaib, Eltahir A.G. Khalil, Lothar H. Wieler, Ulrich E. Schaible, Mohammed A. Bakheit, Saad E. Mohamed-Noor, Mohamed A. Abdalla, Glennah Kerubo, Sönke Andres, Doris Hillemann, Elvira Richter, Katharina Kranzer, Stefan Niemann, Matthias Merker
Publikováno v:
Emerging Infectious Diseases, Vol 26, Iss 3, Pp 427-436 (2020)
Pathogen-based factors associated with tuberculosis (TB) in eastern Sudan are not well defined. We investigated genetic diversity, drug resistance, and possible transmission clusters of Mycobacterium tuberculosis complex (MTBC) strains by using a gen
Externí odkaz:
https://doaj.org/article/c6c721e89d0b4273919fe6176ee07fa0
Autor:
Julia Hansen, Katharina Kolbe, Inke R König, Regina Scherließ, Marie Hellfritzsch, Sven Malm, Sven Müller-Loennies, Julia Zallet, Doris Hillemann, Karl-Heinz Wiesmüller, Christian Herzmann, Julius Brandenburg, Norbert Reiling
Publikováno v:
PLoS ONE, Vol 17, Iss 7, p e0265554 (2022)
BackgroundPulmonary Tuberculosis (TB) is diagnosed through sputum samples. As sputum sampling is challenging in children and cachexic patients, the development of diagnostic tests using saliva appears promising but has been discouraged due to low bac
Externí odkaz:
https://doaj.org/article/168b83c2de15477195c440bfc22ae2d9
Autor:
Helmut J.F. Salzer, Bakari Chitechi, Doris Hillemann, Michael Mandl, Christian Paar, Monika Mitterhumer, Bernd Lamprecht, Florian P. Maurer
Publikováno v:
Emerging Infectious Diseases, Vol 26, Iss 11, Pp 2776-2778 (2020)
The clinical relevance of newly described nontuberculous mycobacteria is often unclear. We report a case of pulmonary infection caused by Mycobacterium hassiacum in an immunocompetent patient in Austria who had chronic obstructive pulmonary disease.
Externí odkaz:
https://doaj.org/article/d28f18fb5e234fbc823a890db25fcc29
Autor:
Hamzah Z. Farooq, Daniela M. Cirillo, Doris Hillemann, David Wyllie, Marieke J. van der Werf, Csaba Ködmön, Vlad Nikolayevskyy
Publikováno v:
Emerging Infectious Diseases, Vol 27, Iss 3, Pp - (2021)
We surveyed availability of phenotypic drug susceptibility testing for drug-resistant Mycobacterium tuberculosis in Europe. Of 27 laboratories, 17 tested for linezolid, 11 for clofazimine, 9 for bedaquiline, and 6 for delamanid during 2019. Our findi
Externí odkaz:
https://doaj.org/article/dad15d3a3fc4462f837e9962c25cb9a2
Autor:
Thu Hang Pham, Jonathan Peter, Fernanda C.Q. Mello, Tommy Parraga, Nguyen Thi Ngoc Lan, Pamela Nabeta, Eloise Valli, Tatiana Caceres, Keertan Dheda, Susan E. Dorman, Doris Hillemann, Christen M. Gray, Mark D. Perkins
Publikováno v:
International Journal of Infectious Diseases, Vol 68, Iss , Pp 44-49 (2018)
Objective: To evaluate the diagnostic performance of TB-LAMP, a manual molecular tuberculosis (TB) detection method, and provide comparison to the Xpert MTB/RIF assay. Methods: In a large multicentre study, two sputum samples were collected from part
Externí odkaz:
https://doaj.org/article/c41bfc034fa8450a854ee4f87c81aad8
Autor:
Stefanie Deinhardt-Emmer, Steffen Höring, Christian Mura, Doris Hillemann, Beate Hermann, Svea Sachse, Jürgen Bohnert, Bettina Löffler
Publikováno v:
Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine, Vol 12 (2018)
We describe the first isolation of Mycobacterium hassiacum , a rapid-growing, partial acid-resistant mycobacterium, in a respiratory specimen from a patient with exacerbated chronic obstructive pulmonary disease. To provide therapeutic recommendation
Externí odkaz:
https://doaj.org/article/0d3294425f6b4ce0812a884de8f60f57